Advanced search
Publication Cover
Expert Review of Anti-infective Therapy Volume 10, 2012 - Issue 11
Submit an article Journal homepage
875
Views
11
CrossRef citations to date
0
Altmetric
Editorial

Influenza antivirals and resistance: the next 10 years?

Aeron C Hurt WHO Collaborating Centre for Reference and Research on Influenza, North Melbourne, Victoria 3051, Australia and Monash University, School of Applied Sciences, Churchill, Victoria 3842, Australia. [email protected]
,
Jeff Butler WHO Collaborating Centre for Reference and Research on Influenza, North Melbourne, Victoria 3051, Australia
,
Anne Kelso WHO Collaborating Centre for Reference and Research on Influenza, North Melbourne, Victoria 3051, Australia
&
Ian G Barr WHO Collaborating Centre for Reference and Research on Influenza, North Melbourne, Victoria 3051, Australia and Monash University, School of Applied Sciences, Churchill, Victoria 3842, Australia
Pages 1221-1223 | Published online: 10 Jan 2014

Citations (11)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Sebastian Schloer, Jonas Goretzko, Alexander Kühnl, Linda Brunotte, Stephan Ludwig & Ursula Rescher. (2019) The clinically licensed antifungal drug itraconazole inhibits influenza virus in vitro and in vivo. Emerging Microbes & Infections 8:1, pages 80-93.
Read now
Nick Spanakis, Vassiliki Pitiriga, Vassiliki Gennimata & Athanassios Tsakris. (2014) A review of neuraminidase inhibitor susceptibility in influenza strains. Expert Review of Anti-infective Therapy 12:11, pages 1325-1336.
Read now

Articles from other publishers (9)

S. A. Eremin, S. V. Ryazantsev, S. I. Sitnikov & S. S. Vysockaya. (2023) Basic therapy for viral diseases of the upper respiratory tract. Meditsinskiy sovet = Medical Council:7, pages 188-195.
Crossref
Samuel Pushparaj, Zhengyu Zhu, Chaoqun Huang, Sunil More, Yurong Liang, Kong Lin, Kishore Vaddadi & Lin Liu. (2022) Regulation of influenza A virus infection by Lnc‐PINK1‐2:5. Journal of Cellular and Molecular Medicine 26:8, pages 2285-2298.
Crossref
Yinghan Chan, Sin Wi Ng, Meenu Mehta, Krishnan Anand, Sachin Kumar Singh, Gaurav Gupta, Dinesh Kumar Chellappan & Kamal Dua. (2020) Advanced drug delivery systems can assist in managing influenza virus infection: A hypothesis. Medical Hypotheses 144, pages 110298.
Crossref
Sebastian Schloer, Jonas Goretzko, Stephan Pleschka, Stephan Ludwig & Ursula Rescher. (2020) Combinatory Treatment with Oseltamivir and Itraconazole Targeting Both Virus and Host Factors in Influenza A Virus Infection. Viruses 12:7, pages 703.
Crossref
Patrick Müller & Kevin M. Downard. (2015) Catechin inhibition of influenza neuraminidase and its molecular basis with mass spectrometry. Journal of Pharmaceutical and Biomedical Analysis 111, pages 222-230.
Crossref
Liwei An, Rui Liu, Wei Tang, Jian-Guo Wu & Xulin Chen. (2014) Screening and identification of inhibitors against influenza A virus from a US drug collection of 1280 drugs. Antiviral Research 109, pages 54-63.
Crossref
Kavya Swaminathan, Patrick Müller & Kevin M. Downard. (2014) Substituent effects on the binding of natural product anthocyanidin inhibitors to influenza neuraminidase with mass spectrometry. Analytica Chimica Acta 828, pages 61-69.
Crossref
Jeff Butler, Kathryn A. Hooper, Stephen Petrie, Raphael Lee, Sebastian Maurer-Stroh, Lucia Reh, Teagan Guarnaccia, Chantal Baas, Lumin Xue, Sophie Vitesnik, Sook-Kwan Leang, Jodie McVernon, Anne Kelso, Ian G. Barr, James M. McCaw, Jesse D. Bloom & Aeron C. Hurt. (2014) Estimating the Fitness Advantage Conferred by Permissive Neuraminidase Mutations in Recent Oseltamivir-Resistant A(H1N1)pdm09 Influenza Viruses. PLoS Pathogens 10:4, pages e1004065.
Crossref
Ding Yuan Oh & Aeron C. Hurt. (2014) A Review of the Antiviral Susceptibility of Human and Avian Influenza Viruses over the Last Decade. Scientifica 2014, pages 1-10.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.